American Century Companies Inc Zymeworks Inc. Transaction History

American Century Companies Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$6.0 - $16.98 $843,288 - $2.39 Million	-140,548 Closed	0 $0
Q2 2021 Aug 05, 2021	SELL	$26.5 - $38.23 $2.11 Million - $3.04 Million	-79,456 Reduced 36.12%	140,548 $4.88 Million
Q1 2021 May 14, 2021	BUY	$29.83 - $56.81 $19,687 - $37,494	660 Added 0.3%	220,004 $6.95 Million
Q4 2020 Feb 12, 2021	BUY	$39.12 - $54.99 $469 - $659	12 Added 0.01%	219,344 $10.4 Million
Q3 2020 Nov 13, 2020	BUY	$29.21 - $46.58 $6.41 Million - $10.2 Million	219,332 New	219,332 $10.2 Million

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $766M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

Stay updated on American Century Companies Inc with notifications on news.